Not applicableUnknownNCT04015193What this trial is testingFollow-up of SPTS in Patients With Raynaud's PhenomenonWho this might be right forRaynaud Phenomenon University Medical Center Groningen 50
Post-approval studies (Phase 4)Ended earlyNCT03639766What this trial is testingThe Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's PhenomenonWho this might be right forRaynaud Phenomenon University of Central Florida 3
Not applicableUnknownNCT03749577What this trial is testingNutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's PhenomenonWho this might be right forRaynaud Phenomenon University Hospital, Grenoble 30
Not applicableStudy completedNCT03129178What this trial is testingBeet the Cold: The Effect of Inorganic Nitrate Supplementation in Individuals With Raynaud's PhenomenonWho this might be right forRaynaud Phenomenon University of Portsmouth 27
Not applicableStudy completedNCT04854850What this trial is testingApollo Device for Fatigue in Systemic SclerosisWho this might be right forSystemic SclerosisFatigueRaynaud Phenomenon Robyn T. Domsic, MD, MPH 25
Large-scale testing (Phase 3)Study completedNCT03717961What this trial is testingEfficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic SclerosisWho this might be right forRaynaud Phenomenon Secondary to Systemic Sclerosis Assistance Publique - Hôpitaux de Paris 91
Post-approval studies (Phase 4)Study completedNCT00048776What this trial is testingSafety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonWho this might be right forRaynaud's Disease Otsuka America Pharmaceutical 75
Large-scale testing (Phase 3)Study completedNCT00419419What this trial is testingPhase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's PhenomenonWho this might be right forRaynaud's DiseaseSclerodermaAutoimmune Diseases MediQuest Therapeutics 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07759557What this trial is testingEfficacy of A Non-Invasive Botulinum Toxin Microneedle Pad for the Treatment of Secondary Raynaud's PhenomenonWho this might be right forSystemic Sclerosis (SSc)Raynaud Disease Secondary to Scleroderma Khon Kaen University 72
Early research (Phase 1)Study completedNCT00841594What this trial is testingMQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic ComparisonWho this might be right forRaynaud's Phenomenon MediQuest Therapeutics 12
Large-scale testing (Phase 3)UnknownNCT00934427What this trial is testingStudy of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon SymptomsWho this might be right forRaynaud Disease MediQuest Therapeutics 100
Testing effectiveness (Phase 2)Study completedNCT02688270What this trial is testingEfficacy and Safety of Vascana® in Subjects With Secondary Raynaud's PhenomenonWho this might be right forRaynaud's Phenomenon Secondary to Connective Tissue Disease Covis Pharma S.à.r.l. 65
Not applicableWithdrawnNCT04898036What this trial is testingPhototherapy For Treatment Of Raynaud's PhenomenonWho this might be right forRaynaud DiseaseRaynaud PhenomenonRaynaud Syndrome University of Minnesota
Not applicableLooking for participantsNCT07196397What this trial is testingPOLish Registry of CArdioneuroablation and CArdioneuromodulationWho this might be right forVasovagal Syndrome VVSCardioinhibitory Carotid Sinus Syndrome CSSSymptomatic Sinus Bradycardia SB or Atrioventricular Block AV+9 more SABAMED Medical Center Ltd. 1,000
Very early researchStudy completedNCT02583789What this trial is testingAssess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's PhenomenonWho this might be right forRaynaud's Phenomenon Brigham and Women's Hospital 12
Not applicableStudy completedNCT02202291What this trial is testingProspective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's PhenomenonWho this might be right forPrimary Raynaud's Phenomenon (PR)Genetic Mutations Causing PRStudy of Patients and Their Relatives (With or Without Primary PR) Nantes University Hospital 258
Large-scale testing (Phase 3)Looking for participantsNCT05098704What this trial is testingPreventive Effect of Clopidogrel on the Systemic Sclerosis Development RiskWho this might be right forSclerodermaSystemic Sclerosis University Hospital, Bordeaux 90
Post-approval studies (Phase 4)Looking for participantsNCT07112183What this trial is testingOpen Label Treprostinil Raynaud's StudyWho this might be right forRaynaud's DiseaseRaynaud PhenomenaRaynauds Brigham and Women's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04388176What this trial is testingCold Challenge With C21 in RPWho this might be right forRaynaud PhenomenonSystemic Sclerosis Vicore Pharma AB 20
Early research (Phase 1)Study completedNCT00700518What this trial is testingDose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's PhenomenonWho this might be right forRaynaud's Phenomenon Procris Pharmaceuticals 10